Clinical guidelines on management of atopic dermatitis in children

Hong Kong Journal of Paediatrics

Volumn 18, Issue 2, 2013, Pages 96-104

  Leung, T N H ^a   Chow, C M ^a   Chow, M P Y ^a   Luk, D C K ^a   Ho, K M ^a   Hon, K L ^a   Sugunan, V K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; AZATHIOPRINE; BECLOMETASONE DIPROPIONATE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; CALCINEURIN INHIBITOR; CLOBETASOL PROPIONATE; CLOBETASONE BUTYRATE; CORTICOSTEROID; CYCLOSPORIN A; DIFLUCORTOLONE VALERATE; EMOLLIENT AGENT; FLUOCINOLONE ACETONIDE; FLUTICASONE; FLUTICASONE PROPIONATE; GAMMA INTERFERON; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE ACEPONATE; MOMETASONE FUROATE; MONTELUKAST; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIMECROLIMUS; PSEUDOMONIC ACID; TACROLIMUS; TRIAMCINOLONE; UNINDEXED DRUG;

ADRENAL SUPPRESSION; ALLERGIC RHINITIS; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; ASTHMA; ATOPIC DERMATITIS; ATOPY; ATROPHY; BANDAGE; BONE MARROW TOXICITY; CHINESE MEDICINE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL PRACTICE; CLOTHING; CUSHING SYNDROME; DIET THERAPY; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG FORMULATION; DRUG INDICATION; DRUG POTENCY; DRUG WITHDRAWAL; DRY SKIN; ECZEMA; ERYTHEMA; FAMILY HISTORY; FOOD ALLERGY; GINGIVA HYPERPLASIA; GROWTH RETARDATION; HERPES SIMPLEX; HUMAN; HYDRATION; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRICHOSIS; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KAPOSI VARICELLIFORM ERUPTION; LIVER TOXICITY; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DOCUMENTATION; MEDICAL HISTORY; NEPHROTOXICITY; ONSET AGE; OSTEOPOROSIS; PATIENT EDUCATION; PERIORAL DERMATITIS; PHOTOTHERAPY; PRACTICE GUIDELINE; PRURITUS; PSYCHOSOCIAL CARE; QUALITY OF LIFE; SCORING SYSTEM; SIDE EFFECT; SKIN ATROPHY; SKIN BURNING SENSATION; SKIN CARE; SKIN DEFECT; SKIN INFECTION; SKIN INJURY; SKIN REDNESS; SKINFOLD; SOCIAL ASPECT; STAPHYLOCOCCAL SKIN INFECTION; STRIA; TACHYPHYLAXIS; TELANGIECTASIA; TOPICAL TREATMENT; TREATMENT DURATION; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT;

EID: 84876479452     PISSN: 10139923     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Wong GW, Leung TF, Ma Y, Liu EK, Yung E, Lai CK. Symptoms of asthma and atopic disorders in preschool children: prevalence and risk factors. Clin Exp Allergy 2007;37:174-9.
2. Lee SL, Wong W, Lau YL. IIncreasing prevalence of allergic rhinitis but not asthma among children in Hong Kong from 1995 to 2001 (Phase 3 International Study of Asthma and Allergies in Childhood). Pediatr Allergy Immunol 2004b;15:72-8.
3. Wong GW, Leung TF, Ko FW, et al. Declining asthma prevalence in Hong Kong Chinese schoolchildren. Clin Exp Allergy 2004; 34:1550-5.
4. National Institute for Health and Clinical Excellence. Atopic eczema in children. Management of atopic eczema in children from birth up to age of 12 years. NICE clinical guideline 57, December 2007. Available at http://guidance.nice.org.uk/CG57.
5. Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy 2006;61:969-87.
6. Hanifin JM, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". J Am Acad Dermatol 2004;50:391-404.
7. Saeki H, Furue M, Furukawa F, et al.; Committee for Guidelines for the Management of Atopic Dermatitis of Japanese Dermatological Assoication. Guidelines for management of atopic dermatitis. J Dermatol 2009;36:563-77.
8. Hon KL, Leung AK. Chapter on Use of Moisturizers in Patients with Atopic Dermatitis. Treatment of Dry Skin Syndrome. Lodén M, Maibach HI (eds.), Springer-Verlag Berlin Heidelberg, 2012.
9. Hon KL, Leung AK. Use of Ceramides and Related Products for Childhood-Onset Eczema. Recent Pat Inflamm Allergy Drug Discov 2012 Oct 17. [Epub ahead of print].
10. Long CC, Finlay AY. The finger-tip unit--a new practical measure. Clin Exp Dermatol 1991;16(6):444-7.
11. NHS Prodigy Guidance on Atopic Eczema. Available at: www.cks.library.nhs.uk/eczema_atopic.
12. Callen J, Chamlin S, Eichenfield LF, et al. A systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol 2007;156:203-21.
13. Topical steroid. In, Vol. 2011: Wikimedia Foundation Inc, 2011.
14. Oranje AP, Devillers AC, Kunz B, et al. Treatment of patients with atopic dermatitis using wet-wrap dressings with diluted steroids and/or emollients. An expert panel's opinion and review of the literature. J Eur Acad Dermatol Venereol 2006;20:1277-86.
15. National Institute for Clinical Excellence. Tacrolimus and pimecrolimus for atopic eczema. Technology Apprasial Guidance 82, August 2004. Available: http://www.nice.org.uk/nicemedia/ pdf/TA082publicinfo.pdf
16. Berger TG, Duvic M, Van Voorhees AS, et al. American Academy of Dermatology Association Task Force. The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force. J Am Acad Dermatol 2006;54:818-23.
17. US Food and Drug Adminstration, US Department of Health and Human Services, 19 January 2006. Available at: http://www. fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ ucm108580.htm.
18. Schmitt J, Schäkel K, Schmitt N, Meurer M. Systemic treatment of severe atopic eczema: a systematic review. Acta Derm Venereol 2007;87:100-11.
19. Harper JI, Ahmed I, Barclay G, et al. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol 2000;142:52-8.
20. Grundmann SA, Beissert S. Modern aspects of phototherapy for atopic dermatitis. J Allergy (Cairo) 2012;121797. Epub 2011 Dec 15.
21. Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009;123:e808-14.
22. 2LEN. Allergy 2007;62:723-8.
23. National Institute for Health and Clinical Excellence. Food allergy in Children and young people. Diagnosis and assessment of aloof allergy in children and young people in primary care and community settings. NICE clinical guideline CG116, Februrary 2011. Available at: http://guidance.nice.org.uk/CG116.
24. Niggemann B, Beyer K. Diagnostic pitfalls in food allergy in children. Allergy 2005;60:104-7.
25. ESPGHAN Committee on Nutrition; Agostoni C, Axelsson I, Goulet O, et al. Soy protein infant formulae and follow-on formulae: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2006;42:352-61.
26. Zhang W, Leonard T, Bath-Hextall FJ, Chambers C, Lee C, Humphreys R, Williams HC. Chinese herbal medicine for atopic eczema. Cochrane Skin Group Cochrane Database of Systematic Reviews. Published in Issue 8, 2010.
27. Hon KL, Chan BCL, Leung PC. Chinese herbal medicine research in eczema treatment. Chin Med 2011;6:17.
28. Ramsay HM, Goddard W, Gill S, Moss C. Herbal creams used for atopic eczema in Birmingham, UK illegally contain potent corticosteroids. Arch Dis Child 2003;88:1056-7.
29. Hon KL, Leung TF, Yau HC, Chan T. Paradoxical use of oral and topical steroids in steroid-phobic patients resorting to traditional Chinese medicines. World J Pediatr 2012;8:263-7.
30. Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000;142: 931-6.
31. Hon KL, Kam WY, Leung TF, et al. Steroid fears in children with eczema. Acta Paediatr 2006;95:1451-5.